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Abstract
Isolated human primary hepatocytes are an essential in vitro model for basic and clinical research. For successful application
as a model, isolated hepatocytes need to have a good viability and be available in sufficient yield. Therefore, this study aims
to identify donor characteristics, intra-operative factors, tissue processing and cell isolation parameters that affect the
viability and yield of human hepatocytes. Remnant liver pieces from tissue designated as surgical waste were collected from
1034 donors with informed consent. Human hepatocytes were isolated by a two-step collagenase perfusion technique with
modifications and hepatocyte yield and viability were subsequently determined. The accompanying patient data was
collected and entered into a database. Univariate analyses found that the viability and the yield of hepatocytes were
affected by many of the variables examined. Multivariate analyses were then carried out to confirm the factors that have a
significant relationship with the viability and the yield. It was found that the viability of hepatocytes was significantly
decreased by the presence of fibrosis, liver fat and with increasing gamma-glutamyltranspeptidase activity and bilirubin
content. Yield was significantly decreased by the presence of liver fat, septal fibrosis, with increasing aspartate
aminotransferase activity, cold ischemia times and weight of perfused liver. However, yield was significantly increased by
chemotherapy treatment. In conclusion, this study determined the variables that have a significant effect on the viability
and the yield of isolated human hepatocytes. These variables have been used to generate an algorithm that can calculate
projected viability and yield of isolated human hepatocytes. In this way, projected viability can be determined even before
isolation of hepatocytes, so that donors that result in high viability and yield can be identified. Further, if the viability and
yield of the isolated hepatocytes is lower than expected, this will highlight a methodological problem that can be
addressed.
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Introduction
The liver carries out a diverse range of necessary functions, such
as homeostasis, metabolism and detoxification. As much of the
research on the liver is human-centric, whether for the elucidation
of mechanisms, translational research or cell-based therapy,
isolated human liver cells remain an important in vitro model
for basic and translational research.
One of the main uses of a human in vitro hepatocyte model is
for the validation of studies done using animal models due to
species differences. Olson et al., [1] showed that when 150 drugs
that cause human toxicity are tested, the concordance between
toxicity found in animal studies and that observed in clinical
practice is 70%. Similarly, Brambilla and Martelli found that
when 42 compounds from various chemical families were tested
for their toxicity in rat or human hepatocytes, 28 had similar
toxicities, 10 were more toxic for rats, 3 were moderately more
toxic for human hepatocytes and 1 was lethal for rat hepatocytes at
a concentration 30-fold lower than that equally toxic for human
hepatocytes [2]. In addition, animal models could also have less
genetic variation than humans; Brambilla and Martell [2] found
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Table 1. Summary of factors affecting the viability of isolated hepatocytes.
Variables Decreased viability No change in viability Increased viability
Age Increased age [12,38] Different ages [15,39] Decreased age* [16]
Gender Male or female [12,13,39]
Fibrosis Fibrotic organs [39] Organs that are not steatotic,
fibrotic or cirrhotic [39]
Cirrhosis Cirrhotic organs [39] Organs that are not steatotic,
fibrotic or cirrhotic [39]
Steatosis Severely steatotic organs or organs that are
not steatotic, fibrotic or cirrhotic [39]
Visually steatotic liver [12]
Disease Malignant disease [15] Colonic secondary, cholangiocarcinoma,
carcinoid, hepatocellular tumour, unknown primary,
hyatid cyst, lung secondary or multi-
organ donors [12], primary biliary cirrhosis or
primary sclerosing cholangitis [9]
Benign disease [15]
Chemotherapy Treated or untreated [14]
Serum enzymes Increased pre-operative
GGT levels [15]
Operation type Right hepatectomy, segmental resection, left hepatectomy,
extended right, local excision or multi-organ donor [12]
Warm ischemia Increased time* [16] Varying time [11], no pringle or varying Pringle times [12]
Cold ischemia .20 h [39] Up to 4 h [12], varying times [38,39] ,10 h [39]
*Statistics done with multiple regression analysis. All other variables were analysed using univariate analyses.
doi:10.1371/journal.pone.0107567.t001
Table 2. Summary of factors affecting the yield of isolated hepatocytes.
Variables Decreased yield No change in yield Increased yield
Age .50 years old [15] Different ages [10,13,39,40]
Gender Male or female [12,13,39]
Fibrosis Fibrotic organs [39] Organs that are not steatotic,
fibrotic or cirrhotic [39]
Cirrhosis Cirrhotic organs [39] Organs that are not steatotic,
fibrotic or cirrhotic [39]
Steatosis Severely steatotic organs [39] No steatosis, ,10% steatosis or .10% steatosis [10],
no steatosis or .10% steatosis [13]
Organs that are not steatotic,
fibrotic or cirrhotic [39]
Disease Malignant disease [15] Benign hepatic diseases, metastases from colorectal cancer,
hepatic primitive malignant tumours or metastases from
non-colorectal cancer [10], colonic secondary, cholangiocarcinoma,
carcinoid, hepatocellular tumour, unknown primary, hyatid cyst,
lung secondary or multi-organ donors [12], benign hepatic
disease, metastases from colorectal cancer, hepatic primitive
malignant tumours or metastases from non-colorectal cancer [13],
primary biliary cirrhosis or primary sclerosing cholangitis [9]
Benign disease [15]
Chemotherapy Treated or untreated [10,14]
Serum enzymes Increased pre-operative GGT
levels [10]
Increased pre-operative ALT or AST levels [10]
Operation type Right hepatectomy, segmental resection, left hepatectomy,
extended right, local excision or multi-organ donor [12]
Warm ischemia Intermittent clamping [13] Varying time [11],no pringle or varying Pringle times [12],
no clamping, continuous or intermittent clamping [13]
No clamping [13]
Cold ischemia Up to 4 h [12], up to 5 h [13], varying times [39]
Perfused liver 100–200 g liver pieces [12],
increased liver weight [16]
Varying weights [10,13]
doi:10.1371/journal.pone.0107567.t002
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that the inter-individual variability in hepatocyte responses to
chemicals that cause cytotoxicity is greater for humans than for
rats. This would make it harder to detect idiosyncratic drug-
induced liver injury.
The usage of human hepatocytes comes with the additional
advantage of following the 3R ethical framework [3] to replace the
use of research animals when possible. This is as the liver tissue
used in this study was obtained from human elective liver
resections. After resection, the tissue was immediately brought to
a pathologist, who would take what was required for histopath-
ological evaluation. The rest of the tissue, which is not needed, was
designated as surgical waste. If a patient had signed an informed
Table 3. Variables considered for statistical analyses.
Variables Categories Abbreviation Unit
Donor characteristics
Age - -
Gender Male or female - -
Body mass index BMI -
Fibrosis Yes or no - -
Cirrhosis Yes or no - -
Diabetes Yes or no - -
Obesity Yes or no - -
Hypertension Yes or no - -
Hypercholesterolemia Yes or no - -
Hyperuricemia Yes or no - -
Smoking Yes, no or ex-smoker - -
Cigarettes per day - -
Liver fat Yes or no - -
Liver fat - %
Tumour type Benign or malignant - -
Surgical indication Hepatocarcinoma (HCC), metastasis, focal
nodular hyperplasia (FNH), klatskin, adenoma,
cholangiocarcinoma (CCC) or others
- -
Chemotherapy Treated or untreated - -
ASA physical status classification system 1, 2, 3 or 6 ASA -
Ludwig score No or minimal fibrotic changes, periportal
fibrosis, septal fibrosis or cirrhosis
- -
Clinical chemistry results before operation
Alkaline phosphatase activity AP U/L
Aspartate aminotransferase activity GOT U/L
Gamma-glutamyltranspeptidase activity GGT U/L
Alanine aminotransferase activity GPT U/L
Cholinesterase activity CHE U/L
Bilirubin - mg/dL
Partial thromboplastin time PTT s
Quick value - %
Operation parameters
Operation type Hemihepatectomy right (HR),
Hemihepatectomy left (HL), segment
resection (SR), atypical resection (AR)
extended hepatectomy (EH), liver
transplantation (LT) or lobectomy (L)
- -
Warm ischemia in vivo - min
Warm ischemia ex vivo - min
Weight of resected liver - g
Tissue processing and cell isolation parameters
Cold ischemia - min
Weight of perfused liver - g
doi:10.1371/journal.pone.0107567.t003
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consent [4], this discarded tissue could then be collected for
hepatocyte isolation.
In order to successfully use human hepatocytes as an in vitro
model or for cell-based therapy, hepatocytes must be obtained
with good viability and hence quality. Further, as the sources of
human hepatocytes are limited and the cost of the entire process
from informed consent to successfully obtaining hepatocytes is
high, it is also important to understand the factors that can result
in a compromised yield. Thus far, the literature on factors that
affect viability and yield is contradictory (Tables 1 and 2). Further,
the previously done studies had a small sample size ranging from
10 to 149 donors. Therefore, this study aimed to determine, with a
large number of donors and hepatocyte isolations carried out over
10 years, the donor characteristics, medical histories and
Table 4. The number of replicates (N) and the P values obtained after linear regression of the individual variables listed below to
viability (%) or yield (million hepatocytes/g liver) of isolated human hepatocytes.
Variables Viability
1 Yield2
N P value N P value
Donor characteristics
Age 1030 0.027* 1026 0.00067*
Gender 1032 6.361027* 1028 1.661026*
Body mass index3 1006 0.022* 1002 0.026*
Fibrosis 910 0.0016* 905 0.074
Cirrhosis 907 0.76 902 1.161025*
Diabetes 1014 0.23 1009 0.022*
Obesity 1015 0.89 1010 0.44
Hypertension 1014 0.21 1009 0.052
Hypercholesterolemia 1012 0.32 1007 0.87
Hyperuricemia 1010 0.48 1005 0.037*
Smoking 573 0.93 569 0.091
Liver fat 886 0.00052* 881 0.021*
Liver fat (%) 522 0.47 517 3.661028*
Tumour type 995 0.51 991 0.063
Surgical indication 1017 0.053 1013 1.661026*
Chemotherapy 1027 0.31 1023 3.561025*
ASA physical status classification system 990 0.90 986 0.054
Ludwig score 813 0.0010* 809 7.561025*
Clinical chemistry results before operation
Alkaline phosphatase activity (U/L)3 797 0.067 792 7.361025*
Aspartate aminotransferase activity (U/L)3 712 0.00012* 709 0.00016*
Gamma-glutamyltranspeptidase activity (U/L)3 690 0.0015* 687 4.261027*
Alanine aminotransferase activity (U/L)3 812 2.961025* 808 2.761029*
Cholinesterase activity (U/L)3 714 0.97 713 0.74
Bilirubin (mg/dL)3 810 0.0022* 805 0.00087*
Partial thromboplastin time (s)3 799 0.88 794 0.035*
Quick value (%) 803 0.027* 798 0.015*
Operation parameters
Operation type 992 0.16 989 3.361028*
Warm ischemia in vivo (min)3 602 0.47 602 0.00068*
Warm ischemia ex vivo (min)3 888 3.961025* 887 0.00054*
Weight of resected liver (g)3 839 0.092 836 0.00066*
Tissue processing and cell isolation parameters
Cold ischemia (min)3 913 0.027* 914 0.19
Weight of perfused liver (g)3 1030 0.68 1027 1.2610211*
*Significant at P,0.05. Data are transformed to follow a normal distribution by logit1, fourth root2 or natural logarithm3 transformation.
doi:10.1371/journal.pone.0107567.t004
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operation, tissue processing and cell isolation parameters that
affect the viability and the yield of isolated human hepatocytes.
Material and Methods
Ethics Statement
The liver pieces used for hepatocyte isolation were collected
from resected liver specimens designated as surgical waste after
examination by a pathologist. In particular, the tissue used was
dissected from the resection margin of tumours containing
morphologically healthy tissue. All liver pieces were collected with
their associated clinical data by the Tissue Bank under the
Administration of the Human Tissue and Cell Research (HTCR)
Foundation (http://www.htcr.de/english/contacts.html) [4]. The
HTCR-process included written informed consent, was approved
by the Ethics Committee of the Medical Faculty of Regensburg
University Hospital (approval number 99/46) and Ethics Com-
mittee of the Medical Faculty of Ludwig Maximilians University
(approval number 025-12) and complied with the Bavarian Data
Protection Act.
Patients
In total, hepatocytes were isolated from remnant liver pieces
from 1034 patients from Regensburg University Hospital
(December 1997 to December 2002 and July 2010 to December
2011) and Grosshadern Hospital located in Munich (January 2003
to December 2013).
Corresponding data on the donor characteristics, medical
histories and operation, tissue processing and cell isolation
parameters were collected and entered into a database. The
variables of interest for this study are listed on Table 3.
Isolation of Human Hepatocytes
Primary human hepatocytes were isolated using a two-step
collagenase perfusion technique [5,6] with modifications [7]. In
short, the larger blood vessels on a liver piece with one cut face
were cannulated with irrigation cannulae with olive tips. The liver
piece was then perfused first with 1 L of Solution 1, which contains
154 mM sodium chloride, 20 mM HEPES, 5.6 mM potassium
chloride, 5 mM glucose and 25 mM sodium hydrogen carbonate.
Next, it was perfused for 10 min with Solution 2 (152.5 mM
sodium chloride, 19.8 mM HEPES, 5.5 mM potassium chloride,
5 mM glucose and 24.8 mM sodium hydrogen carbonate and
0.1 mM EGTA) followed by Solution 3 (152.5 mM sodium
chloride, 19.8 mM HEPES, 5.5 mM potassium chloride, 5 mM
glucose and 24.8 mM sodium hydrogen carbonate and 0.5 mM
calcium chloride dihydrate) for 0.5 L. Finally, it was perfused with
Solution 4 (120 mM sodium chloride, 10 mM HEPES, 0.9 mM
calcium chloride dehydrate, 6.2 mM potassium chloride and 0.1%
w/v albumin), which contains 0.1 to 0.15% w/v collagenase for 9
to 12 minutes or until the liver is sufficiently digested. The liver
piece was then placed carefully in a crystallising dish for removal of
the Glisson’s capsule before gently shaking the cells loose. The cell
suspension was then filtered through a 210 mm nylon mesh
followed by a 70 mm nylon mesh before centrifuging at 72 g for
5 min at 4uC to pellet the hepatocytes. Hepatocytes were then
washed 3 times before resuspending the cells in Cold Storage
Solution (Hepacult GmbH, Germany).
A hemocytometer-based trypan blue dye exclusion assay was
done to quantify the viability and total cells yielded by this
isolation procedure.
Statistical Analyses
The data were summarised by adequate measures of location
and spread. For modelling the outcomes of ‘‘viability’’ and ‘‘yield’’,
linear regression modelling was used when the variables in Table 3
were considered.
To account for the possibility of non-linear relationships
between the considered outcome and the continuous covariates
(Table 3), fractional polynomials of first and second degree were
applied. For this purpose, the multivariable fractional polynomials
(MFP) algorithm [8] was used. This algorithm combines the
selection of the functional forms of each continuous covariate
using fractional polynomials with the selection of all continuous
and non-continuous covariates via backward elimination. For the
multiple regression models, only donors with a complete set of
information for the variables of interest were used. Therefore, 218
donors were considered for viability and 128 donors were
considered for yield. The selection level for potential predictors
was set to 0.05.
In order to satisfy the assumption of normality, viabilities were
transformed by applying the logit and yields by applying the fourth
root. Graphical procedures were used to assess the fit of the model.
All tests were performed two-sided and a p-value lower than 0.05
Table 5. The regression coefficients (b), P values and R2 numbers of variables after multivariate analyses for the dependent






Liver fat 20.22 0.0065*
Clinical chemistry results before operation
Gamma-glutamyltranspeptidase activity (U/L)2 20.088 0.017*
Bilirubin 20.17 0.0095*
R2 = 0.12, Intercept = 1.81
Variables presented are chosen by backward elimination.
*Significant at P,0.05, with N = 218. Data are transformed to follow a normal distribution by logit1 or natural logarithm2 transformation.
doi:10.1371/journal.pone.0107567.t005
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was considered statistically significant. For all statistical analyses
the software R (version 2.13.1) was used.
Results
A total of 1034 hepatocyte isolations were done with an average
viability of 78610% and average yield of 13611 million viable
hepatocytes per gram liver with the values represented in means 6
standard deviation.
Univariate analyses to determine relationships of
variables to viability and yield of hepatocytes
After linear regression analyses were carried out, variables with
or without a significant relationship to the viability and the yield of
hepatocytes were listed in Tables 4 and 5 respectively. In addition,
figures were generated for the variables with significant relation-
ships to the viability (Figures 1 to 4) and the yield (Figures 5 to 9)
of hepatocytes.
It was found that the viability of hepatocytes was decreased by
increases in age, body mass index (BMI), aspartate aminotrans-
ferase (GOT) activity, gamma-glutamyltranspeptidase (GGT)
activity, alanine aminotransferase (GPT) activity, bilirubin content
in the blood, quick value, warm ischemia time in vivo and cold
ischemia time (Table S1). In addition, the viability of hepatocytes
was also decreased for males and for donors with fibrosis, liver fat
or Ludwig scores indicating periportal fibrosis or septal fibrosis
(Table S1).
In the case of the yield of hepatocytes, it was found that the yield
was decreased by increases in age, BMI, liver fat, alkaline
phosphatase (AP) activity, GOT activity, GGT activity, GPT
activity, bilirubin content in the blood, partial thromboplastin time
(PTT), warm ischemia time in vivo and weight of resected or
perfused liver (Table S2). Further, the yield of hepatocytes was also
decreased for males and for donors with cirrhosis, diabetes,
hyperuricemia or certain surgical indications, operation types or
Ludwig scores (Table S2). However, the yield of hepatocytes can
be increased by increases in warm ischemia time ex vivo, Quick
value and in donors treated with chemotherapy (Table S2).
Multivariate analyses to determine the variables that
affect the viability and the yield of hepatocytes
After multivariate analysis, the number of variables that have a
significant effect on the viability of hepatocytes was reduced to 4
variables. It was found that the viability of hepatocytes was
significantly decreased by the presence of fibrosis, liver fat and
with increasing GGT activity and bilirubin content (Table 5).
For the yield of hepatocytes, it was found that yield was
significantly decreased by the presence of liver fat and a Ludwig
score indicating septal fibrosis. In addition, the yield of hepatocytes
was decreased by increasing GOT activity, cold ischemia time and
weight of perfused liver. However, the yield of hepatocytes was
increased with chemotherapy treatment (Table 6).
Figure 1. Donor characteristics that have significant relation-
ships with the viability (%) of hepatocytes after linear
regression analyses. Figures show relationships between viability
and (A) age, (B) gender or (C) body mass index (BMI). Values were
deemed significant when P,0.05.
doi:10.1371/journal.pone.0107567.g001
Prediction of Viability and Yield of Isolated Hepatocytes
PLOS ONE | www.plosone.org 6 October 2014 | Volume 9 | Issue 10 | e107567
Figure 2. Variables measured in the blood or serum that have significant relationships with the viability (%) of hepatocytes after
linear regression analyses. Figures show relationships between viability and (A) aspartate aminotransferase activity (GOT; U/L), (B) gamma-
glutamyltranspeptidase activity (GGT; U/L), (C) alanine aminotransferase activity (GPT; U/L), (D) bilirubin (mg/dL) or (E) quick value (%). Values were
deemed significant when P,0.05.
doi:10.1371/journal.pone.0107567.g002
Prediction of Viability and Yield of Isolated Hepatocytes
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Generation of a model that allows for the calculation of
projected viability and yield of hepatocytes
The information obtained from the multivariate analyses
allowed the generation of formulae for the calculation of projected
viability and the yield of isolated human hepatocytes as shown
below.
For the calculation of projected viability (%) of
hepatocytes
Formula 1. Linear predictor of viability
= b0+b16loge(bilirubin)+b26fibrosis+b36liver fat+b46loge(GGT+1)
The values of the various constants are as follows; b0 = 1.809,
b1 = 20.169, b2 = 20.178, b3 = 20.216 and b4 = 20.088. While
the continuous variables can be directly substituted with the
absolute values recorded for a patient, categorical variables have to
be substituted with ‘‘0’’ or ‘‘1’’. For ‘‘fibrosis’’ – ‘‘0’’ for donors
with no fibrosis and ‘‘1’’ for donors with fibrosis; for ‘‘liver fat’’ –
‘‘0’’ for donors with no liver fat and ‘‘1’’ for donors with liver fat.
Formula 2. Viability (%) = e(linear predictor of viability)4(1+e(linear
predictor of viability))6100
For the calculation of projected yield (million
hepatocytes/g liver)
Formula 3. Linear predictor of yield
= b0+b16Chemotherapy+b26loge(Cold ischemia+1)+b36loge
(Weight of perfused liver+1)+b46Liver fat (%)+b56(Ludwig score)
Cirrhosis+b6 (Ludwig score) Periportal fibrosis+b76(Ludwig
score) Septal fibrosis+b86loge(GOT activity+1)
The values of the various constants are as follows; b0 = 3.137,
b1 = 0.19, b2 = 20.099, b3 = 20.159, b4 = 20.007, b5 = 20.108,
b6 = 0.042, b7 = 20.211 and b8 = 20.114. While the continuous
variables can be directly substituted with the absolute values
recorded for a patient, categorical variables have to be substituted
with ‘‘0’’ or ‘‘1’’. For ‘‘chemotherapy’’ – ‘‘0’’ for donors with no
chemotherapy and ‘‘1’’ for donors treated with chemotherapy; for
the variable ‘‘Ludwig score’’, the Ludwig score category of the a
donor should be set to ‘‘1’’ while all other not applicable Ludwig
score categories should be set to ‘‘0’’ for calculation. For example,
if the donor has ‘‘cirrhosis’’, this variable should be set to 1 at the
same time as setting the variables ‘‘periportal fibrosis’’ and ‘‘septal
fibrosis’’ to 0.
Formula 4. Yield (million hepatocytes/g liver) = linear pre-
dictor of yield4
Validation of the models for calculating projected
viability and yield of isolated hepatocytes
The appropriateness of the models for calculating the projected
viability and yield of isolated hepatocytes are very similar and can
be seen in Figures 10 and 11 respectively. Firstly, the residuals
versus fitted plots (Figures 10A and 11A) show that there is no
systematic relationship between the residuals and the predicted (or
so-called fitted) values. These two figure panels (Figures 10A and
Figure 3. Liver variables that have significant relationships
with the viability (%) of hepatocytes after linear regression
analyses. Figures show relationships between viability and (A) fibrosis,
(B) liver fat or (C) Ludwig score. Values were deemed significant when
P,0.05. For the variable of Ludwig score, variables not sharing the
same alphabet are significantly different, P,0.05.
doi:10.1371/journal.pone.0107567.g003
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11A) also show that there are no systematic tendencies in the
errors, such as heteroscedasticity etc.
Secondly, the normal quintile plots (Figures 10B and 11B) show
that the residuals are approximately normally distributed. This
distribution is necessary in order to obtain valid test statistics and P
values of the regression coefficient.
Thirdly, the square root of the standardised residuals versus
fitted plots (Figures 10C and 11C) show that there is no systematic
relationship between the residuals and the predicted (or fitted)
values. As before, these graphs also do not show systematic
tendencies in the errors such as heteroscedasticity. However, in
contrast to the residuals versus fitted plot, the standardised
residuals were normalised once again, so that the residuals to have
unit variance, using an overall measure of the error variance.
Finally, the standardised residuals versus leverage plots (Figur-
es 10D and 11D) show the influence of regression results when
leaving out a single observation from the dataset. Leverage can be
used to detect multivariate outliers in the data, but in this case, the
leverage is so small that no limits indicating big leverage of a single
or several observations appear in our data.
Discussion
This study aimed to determine donor characteristics, medical
histories and operation, tissue processing and cell isolation
parameters that affect the viability and the yield of isolated
human hepatocytes. In order to do this, univariate analyses were
first run to determine the variables that had a significant
relationship to the viability or the yield of isolated human
hepatocytes. Next, multiple regression analyses were run to
determine the relative contributions of the various variables on
the outcomes of viability and yield. From the results of the multiple
regression analyses, a model was built to predict the viability and
the yield of isolated hepatocytes (see Formulae 1–4 in results).
Residual analyses were then done to check the regression
assumptions in order to ensure that the model was appropriate.
This study has to the authors’ knowledge, the largest number of
donors examined for univariate analyses with 1034 donors and a
sample size between 517 and 1032 for the individual variables. In
contrast, other studies that carried out univariate analyses had
sample sizes between 10 and 149 [9–15]. As a result, this study
detects statistical significance in more variables than in the other
studies (Tables 4, S1 and S2), probably due to an increase in
statistical power. However, when multiple regression analyses were
done, a reduced number of variables were found to be statistically
significant. Typically, this is the case when multiple regression
analyses are carried out, but it is important to consider that there is
a loss of statistical power as the sample sizes were 218 for viability
and 128 for yield of isolated hepatocytes as only cases with
completed data on all the variables of interest were considered.
However, as the other study that has conducted multiple
regression analyses to the authors’ knowledge has a sample size
of 90 [16], this study still contributes useful information that will be
discussed below.
When the absolute viability and yield numbers are considered,
the hepatocytes isolated according to the authors’ protocol [7]
have a good balance of high viability (7760.3) and yield
(13.460.4) comparable to other groups with good results
(Table 7). The comparison of variables found to have significant
effects on the viability and yield of hepatocytes to what is known in
the literature is challenging, as the results obtained by other groups
are often contradictory (Tables 1 and 2). As such, the following
paragraphs will instead focus on discussing the results of the
multiple regression analyses.
After multiple regression analyses, this investigation has found
that the viability of isolated human hepatocytes was significantly
decreased by the presence of fibrosis, liver fat and with increasing
GGT activity and bilirubin content (Formula 1). In the case of the
Figure 4. Tissue processing and cell isolation variables that have significant relationships with the viability (%) of hepatocytes after
linear regression analyses. Figures show relationships between viability and (A) warm ischemia ex vivo (min) or (B) cold ischemia (min). Values
were deemed significant when P,0.05.
doi:10.1371/journal.pone.0107567.g004
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Figure 5. Donor characteristics that have significant relationships with the yield (million hepatocytes/gram liver) after linear
regression analyses. Figures show relationships between yield and (A) age, (B) gender, (C) body mass index (BMI), (D) diabetes, (E) hyperuricemia
or (F) chemotherapy. Values were deemed significant when P,0.05.
doi:10.1371/journal.pone.0107567.g005
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yield of isolated human hepatocytes, it was found that the yield
was significantly decreased by the presence of liver fat, a Ludwig
score indicating septal fibrosis and by increasing GOT activity,
cold ischemia time and weight of perfused liver. Further, the yield
of hepatocytes was increased with chemotherapy treatment
(Formula 3).
Increased cold ischemia time has been found to decrease the
yield of isolated hepatocytes. In this study, the liver piece used for
hepatocyte isolation was not perfused to remove the blood in the
tissue before transport on ice to the laboratory. As a result, the
formation of blood clots can occur in the tissue in the cases with
longer transportation times even though the clotting process is
slowed by low temperatures [17]. This could then affect the
perfusion of the liver during the hepatocyte isolation process and
decrease the yield. Yield is also decreased when the weight of the
perfused liver is increased. Alexandre et al. [10] showed that the
percentage of undigested tissue left after the isolation process is
significantly increased in larger pieces of liver above 101 g. Also,
Figure 6. Variables measured in the blood or serum that have significant relationships with the yield (million hepatocytes/gram
liver) after linear regression analyses. Figures show relationships between yield and (A) alkaline phosphatase activity (AP; U/L), (B) aspartate
aminotransferase activity (GOT; U/L), (C) gamma-glutamyltranspeptidase activity (GGT; U/L), (D) alanine aminotransferase activity (GPT; U/L), (E)
bilirubin (mg/dL), (F) partial thromboplastin time (PTT; s) or (G) quick value (%). Values were deemed significant when P,0.05.
doi:10.1371/journal.pone.0107567.g006
Figure 7. Liver variables that have significant relationships with the yield (million hepatocytes/gram liver) of hepatocytes after
linear regression analyses. Figures show relationships between yield and (A) cirrhosis, (B) liver fat, (C) liver fat (%) or (D) Ludwig score. Values
were deemed significant when P,0.05. For the variables of Ludwig score, operation type and surgical indication, variables not sharing the same
alphabet are significantly different, P,0.05.
doi:10.1371/journal.pone.0107567.g007
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the isolation set-up used in this study can provide a maximum of 8
cannulae for perfusing the liver piece [7]. Although the rate of
perfusion per cannula is kept at similar levels independent of the
size of the liver [7], it may be that portions of a larger liver are not
perfused due to additionally available open blood vessels not being
cannulated.
Fibrosis develops in response to many types of chronic liver
diseases [18]. In such diseases, apoptosis plays a critical role both
in liver injury and the subsequent fibrosis [18]. During the process
of apoptosis, hepatocytes form apoptotic bodies that are phago-
cytosed by hepatic stellate cells resulting in an up-regulation of
Transforming Growth Factor b (TGF-b) and procollagen a1,
leading to subsequent inflammation and fibrogenesis [19–21].
Since fibrosis is closely linked with inflammation and cell death, it
is not surprising that hepatocytes isolated from fibrotic livers have
a significantly lower viability. In particular, this study found that
septal fibrosis resulted in a significantly decreased yield of viable
hepatocytes. The process of septal fibrosis begins with the
extension of the septa between central veins through interhepa-
tocellular space and the space of Disse on the sides of the sinusoids
[22]. As fibrosis proceeds, capillarization and then venularization
occurs [22,23]. During this process, the fenestrations in some
hepatic sinusoids are lost and the development of basal laminae
occur alongside the collagenization of the extravascular spaces of
Figure 8. Operation variables that have significant relationships with the yield (million hepatocytes/gram liver) of hepatocytes
after linear regression analyses. Figures show relationships between yield and (A) surgical indication, (B) operation type, (C) warm ischemia in
vivo (min) or (D) weight of resected liver (g). Values were deemed significant when P,0.05. Abbreviations; hepatocarcinoma (HCC), focal nodular
hyperplasia (FNH), cholangiocarcinoma (CCC), hemihepatectomy right (HR), hemihepatectomy left (HL), segment resection (SR), atypical resection
(AR), extended hepatectomy (EH), lobectomy (L) and liver transplantation (LT).
doi:10.1371/journal.pone.0107567.g008
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Disse [22,24]. This capillarization and fibrosis has been postulated
to impair the leakage of macromolecules by creating a new barrier
between the sinusoids and the hepatocytes [24]. This assertion has
been supported by an approach utilising MRI, which shows that
the extravascular distribution of high molecular weight contrast
agents (6 or 52 kDa) is limited in a model of sinusoidal fibrosis
[24]. These observations could explain the decreased yield
obtained in this study due to septal fibrosis as collagenase that is
110 kDa will have limited access to the extracellular matrix in the
direct vicinity of hepatocytes. Together with an increased amount
of collagen surrounding capillaries that have to be digested, it is
likely that the release of hepatocytes into a cell suspension is
impaired and hence the reduced yield.
The presence of liver fat results in a significant decrease in the
viability of hepatocytes. Hepatic steatosis, which is commonly
found in obese or heavy alcohol drinkers, has been postulated to
Figure 9. Tissue processing and cell isolation variables that have significant relationships with the yield (million hepatocytes/gram
liver) of hepatocytes after linear regression analyses. Figures show relationships between yield and (A) warm ischemia ex vivo (min) or (B)
weight of perfused liver (g). Values were deemed significant when P,0.05.
doi:10.1371/journal.pone.0107567.g009
Table 6. The regression coefficients (b), P values and R2 numbers of variables after multivariate analyses for the dependent





Liver fat (%) 20.0069 0.0056*
Chemotherapy 0.19 0.0036*
Ludwig score
-No or minimal fibrotic changes (reference) - -
-Periportal fibrosis 0.042 0.56
-Septal fibrosis 20.21 0.047*
-Cirrhosis 20.11 0.52
Clinical chemistry results before operation
Aspartate aminotransferase activity (U/L)2 20.11 0.016*
Tissue processing and cell isolation parameters
Cold ischemia (min)2 20.099 0.042*
Weight of perfused liver (g) 20.16 0.0018*
R2 = 0.32, Intercept = 3.14
Variables presented are chosen by backward elimination.
*Significant at P,0.05, with N = 128. Data are transformed to follow a normal distribution by fourth root1 or natural logarithm2 transformation.
doi:10.1371/journal.pone.0107567.t006
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be a ‘‘first hit’’ that increases sensitivity to a ‘‘second hit’’ that
could then trigger a cascade leading to steatohepatitis [25].
Steatohepatitis is characterised by inflammation and liver cell
damage and could therefore lead to lower hepatocyte viability.
Further, steatotic hepatocytes have been found to have increased
sensitivity to hypoxic injury i.e. lower viability, due to the
attenuation of Hypoxia Inducible Factor 1a expression and
protein accumulation [26]. The presence of liver fat also results
in a significant decrease in the yield of hepatocytes. It has been
found that fat accumulation in hepatocytes results in microvascu-
lar alterations [27]. Various studies have demonstrated that lipid
accumulation results in enlargement of hepatocytes, which widen
the parenchymal cell plates, narrow and distort the lumens of the
sinusoids and hence reduce the intrasinusoidal volume [27]. As a
result, the sinusoids have impaired tissue perfusion and become
poor conduits for conducting the collagenase-containing buffer
used in the cell isolation process and possibly leading to a lower
yield of hepatocytes. In addition, during centrifugation steps in the
isolation process, steatotic hepatocytes tend to form a pellet less
effectively, making it more likely that hepatocytes are lost when the
supernatant is aspirated off (Authors’ observation).
Levels of bilirubin and activities of GGT and GOT in the serum
are standard assay parameters in liver function tests. Elevated
levels of bilirubin and GGT, known indicators of hepatocyte injury
[28,29], have been found here to lower viability of isolated
hepatocytes. Increased activity of GOT significantly decreased the
yield of hepatocytes. This could be because a high level of GOT
has been found to be a diagnostic marker for a number of diseases
that can affect microcirculation or have increased collagen
deposition, such as advanced alcoholic disease [30] or non-
alcoholic chronic liver diseases with significant fibrosis [31,32],
Figure 10. The model for calculating projected viability is appropriate. (A) Residuals versus fitted plot. (B) Normal quantile plot. (C) Square
root of the standardised residuals versus fitted plot. (D) Standardised residuals versus leverage plot.
doi:10.1371/journal.pone.0107567.g010
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Hewes et al. [14] found that previous chemotherapy does not
affect the median yield of isolated human hepatocytes (4.6 million
viable cells per gram of liver). In contrast, this study found a
significantly increased yield of hepatocytes from donors pre-
treated with chemotherapy with median yields of 17 compared to
10 million viable cells per gram of liver from donors without
chemotherapy. It could be possible that the analysis done here was
able to pick up a significance due to an increased statistical power,
as this study has 128 replicates compared to 47 replicates done in
Hewes et al.’s study [14]. An additional support for this reasoning
is that the univariate analysis done with 1027 replicates also
indicated a statistical difference (P = 3.561025). It is possible that
chemotherapy has reduced extracellular matrix proteins, such as
collagen, allowing for a more complete digestion of the liver piece
with collagenase, which resulted in an increased yield of isolated
hepatocytes. This is supported by the study of Drózdz and
Kucharz [33], which found that a cytostatic drug, azathioprine
caused a decrease in total collagen content in the liver. Further,
Sorefenib, a drug that is approved for the treatment of
hepatocarcinoma has been found to act as an antifibrotic agent
that reduced collagen deposition in fibrosis models such as bile
duct ligation, thioacetamide or dimethylnitrosamine administra-
tion in rats or carbon tetrachloride administration in mice [34–
36]. Doxorubicin, another commonly used chemotherapeutic
drug, also reduces collagen content in bile duct ligated rats by
strongly inhibiting hepatic stellate cell proliferation [37].
In conclusion, this study has determined the variables that affect
the viability and yield of isolated human hepatocytes. Further, this
study has generated algorithms (Formulae 1–4) for the prediction of
the viability or yield. A publicly accessible webpage (http://www.
Figure 11. The model for calculating projected yield is appropriate. (A) Residuals versus fitted plot. (B) Normal quantile plot. (C) Square root
of the standardised residuals versus fitted plot. (D) Standardised residuals versus leverage plot.
doi:10.1371/journal.pone.0107567.g011
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klinikum.uni-muenchen.de/Chirurgische-Klinik-und-Poliklinik-
Grosshadern/de/0700-forschung/ag-leberregeneration/core-facility/
Qualitaetsrechner_Hepatozyten.html) where researchers can key in
their variables for the automatic calculation of projected viability
and yield using JavaScript, has been made available for ease of use.
It is hoped that this resource will prove useful for the selection of
suitable donors for hepatocyte isolation and also as a reference so
that procedural problems can be spotted due to an unanticipated
lower viability and yield obtained.
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